- 2022 - 2025 患者由来ゼノグラフトを用いたCDK12変異前立腺癌のPARP阻害薬不応性の克服
- 2022 - 2025 遺伝子改変尿路上皮オルガノイドによる膀胱発癌メカニズムの解明と免疫治療のモデル化
- 2021 - 2024 前立腺導管癌の分子生物学的特徴及び治療予測への人工知能の応用
- 2021 - 2024 Development of novel biomarkers based on HLA epitopes for organ transplantation and hematopoietic stem cell transplantation
- 2019 - 2022 Establishment of a novel mouse model that recapitulates human muscle invasive bladder cancer
- 2015 - 2018 Development of predictive markers for drug-susceptibility in blood by genomic analysis using PDX models
- 2014 - 2017 Elucidation of novel carcinogenesis / development pathway of bladder cancer by using metabolism-related omics analysis
- 2013 - 2017 Development of new animal model of invasive bladder cancer based on new generation OMICS analysis between species
- 2015 - 2016 CXCL1を介した膀胱癌微小環境制御機構とそれに伴う腔内再発・進展機序の解明
- 2013 - 2014 ギャップジャンクションに着目した新たな頻尿治療ターゲットの探求
- 2006 - 2008 新規樹立細胞株とXenograftを用いた前立腺癌に対する治療標的分子の同定
Show all